GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

IX Biopharma 42C.SI · SGD

Health Care · SGX · 🇸🇬 Singapore

Compare

0.45

-4.26%

Close of 6 Nov 2026, in SGD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

IX Biopharma annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SGD.

FY2026FY2025FY2024FY2023FY2022
RevenueSGD 6.9mSGD 7.8mSGD 6.0mSGD 5.9mSGD 14.4m
Operating income−SGD 9.5m−SGD 6.3m−SGD 9.5m−SGD 9.5mSGD 541,000
Net income−SGD 8.0m−SGD 10.1m−SGD 10.8m−SGD 9.6m−SGD 4.6m
Free cash flow−SGD 7.6m−SGD 4.0m−SGD 6.8m−SGD 8.4mSGD 2.9m
Total assetsSGD 25.9mSGD 11.3mSGD 14.6mSGD 24.9mSGD 28.5m
Shareholders' equitySGD 15.4mSGD 365,000SGD 4.3mSGD 15.9mSGD 19.7m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.